Gervonta "Tank" Davis has been the talk of the boxing world over the past month, as many people have been criticizing his performance and decision-making during his March 1 fight against Lamont Roach ...

Canelo Alvarez is set to take on William Scull on May 3. Alvarez olds the WBA, WBC, and the Ring super middleweight titles. Scull the IBF super middleweight champion. Alvarez is aiming to go ...

Boxing. Bivol advises Crawford and analyzes if he can beat Canelo Alvarez Boxing. Crawford admits he won't look to knock out Canelo: "I don't need to take him down, I just want to win" Terence ...

Boxing. Terence Crawford admits he won't look to knock out Canelo Alvarez: "I don't need to take him down, I just want to win" Boxing. Rolly Romero can't stand it and threatens to kneel a fan who ...

Cinco De Mayo is Canelo's holiday we just live in it. As usual Saul "Canelo" Alvarez has a big fight scheduled for Cino De Mayo weekend though this time it will take place in the Middle East.

CANELO ALVAREZ had to reassure even his youngest daughter that Jake Paul is no match for him. The Mexican boxing great was in line to face YouTuber-turned-boxer Paul on May 3 in Las Vegas.

Terence Crawford wants Gervonta Davis to fight on the undercard of his showdown with Canelo Alvarez in September. Crawford is set to compete in the biggest fight of his stellar career, as he looks ...

Forbes contributors publish independent expert analyses and insights. Brian Mazique has covered combat sports and video games since 2011.

This is the same mechanism as Eli Lilly’s next-generation “triple-G” drug retatrutide, which has so far appeared to be the most effective obesity drug in development. In a small early ...

The candidate at the center of the deal, dubbed UBT251, is a triple agonist for glucagon-like peptide-1 (GLP-1), gastric inhibitory polypeptide (GIP) and glucagon. Wegovy already inhibits GLP-1 ...

UBT251, a so-called “triple G” agonist, targets GLP-1, gastric inhibitory polypeptide (GIP) and glucagon. For comparison, Wegovy inhibits GLP-1 while Eli Lilly’s competitor Zepbound ...